img

Global OTC Migraine Medication Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Migraine Medication Market Insights, Forecast to 2034

Over-the-counter (OTC) migraine medications are non-prescription medications that can be purchased directly from a pharmacy or retail store without a doctor's prescription. These medicines are intended to provide relief from the symptoms of migraines, such as headache, nausea, and sensitivity to light and sound.
Market Analysis and InsightsGlobal OTC Migraine Medication Market
Global OTC Migraine Medication market is expected to reach to US$ 4828 million in 2024, with a positive growth of %, compared with US$ 4687 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, OTC Migraine Medication industry is evaluated to reach US$ 5698 million in 2029. The CAGR will be 2.8% during 2024 to 2029.
One of the primary market drivers for headache medicine is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Covers
This report presents an overview of global OTC Migraine Medication market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global OTC Migraine Medication market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson & Johnson
GSK
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Segment by Type
NSAIDs
Acetaminophen
Others

Segment by Application


Drug Stores
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, OTC Migraine Medication introduction, etc. OTC Migraine Medication Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of OTC Migraine Medication
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Migraine Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 NSAIDs
1.2.3 Acetaminophen
1.2.4 Others
1.3 Market by Application
1.3.1 Global OTC Migraine Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Drug Stores
1.3.3 Hospitals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Migraine Medication Market Perspective (2018-2029)
2.2 Global OTC Migraine Medication Growth Trends by Region
2.2.1 OTC Migraine Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Migraine Medication Historic Market Size by Region (2018-2024)
2.2.3 OTC Migraine Medication Forecasted Market Size by Region (2024-2029)
2.3 OTC Migraine Medication Market Dynamics
2.3.1 OTC Migraine Medication Industry Trends
2.3.2 OTC Migraine Medication Market Drivers
2.3.3 OTC Migraine Medication Market Challenges
2.3.4 OTC Migraine Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue OTC Migraine Medication by Players
3.1.1 Global OTC Migraine Medication Revenue by Players (2018-2024)
3.1.2 Global OTC Migraine Medication Revenue Market Share by Players (2018-2024)
3.2 Global OTC Migraine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of OTC Migraine Medication, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global OTC Migraine Medication Market Concentration Ratio
3.4.1 Global OTC Migraine Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Migraine Medication Revenue in 2022
3.5 Global Key Players of OTC Migraine Medication Head office and Area Served
3.6 Global Key Players of OTC Migraine Medication, Product and Application
3.7 Global Key Players of OTC Migraine Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Migraine Medication Breakdown Data by Type
4.1 Global OTC Migraine Medication Historic Market Size by Type (2018-2024)
4.2 Global OTC Migraine Medication Forecasted Market Size by Type (2024-2029)
5 OTC Migraine Medication Breakdown Data by Application
5.1 Global OTC Migraine Medication Historic Market Size by Application (2018-2024)
5.2 Global OTC Migraine Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Migraine Medication Market Size (2018-2029)
6.2 North America OTC Migraine Medication Market Size by Type
6.2.1 North America OTC Migraine Medication Market Size by Type (2018-2024)
6.2.2 North America OTC Migraine Medication Market Size by Type (2024-2029)
6.2.3 North America OTC Migraine Medication Market Share by Type (2018-2029)
6.3 North America OTC Migraine Medication Market Size by Application
6.3.1 North America OTC Migraine Medication Market Size by Application (2018-2024)
6.3.2 North America OTC Migraine Medication Market Size by Application (2024-2029)
6.3.3 North America OTC Migraine Medication Market Share by Application (2018-2029)
6.4 North America OTC Migraine Medication Market Size by Country
6.4.1 North America OTC Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America OTC Migraine Medication Market Size by Country (2018-2024)
6.4.3 North America OTC Migraine Medication Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe OTC Migraine Medication Market Size (2018-2029)
7.2 Europe OTC Migraine Medication Market Size by Type
7.2.1 Europe OTC Migraine Medication Market Size by Type (2018-2024)
7.2.2 Europe OTC Migraine Medication Market Size by Type (2024-2029)
7.2.3 Europe OTC Migraine Medication Market Share by Type (2018-2029)
7.3 Europe OTC Migraine Medication Market Size by Application
7.3.1 Europe OTC Migraine Medication Market Size by Application (2018-2024)
7.3.2 Europe OTC Migraine Medication Market Size by Application (2024-2029)
7.3.3 Europe OTC Migraine Medication Market Share by Application (2018-2029)
7.4 Europe OTC Migraine Medication Market Size by Country
7.4.1 Europe OTC Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe OTC Migraine Medication Market Size by Country (2018-2024)
7.4.3 Europe OTC Migraine Medication Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China OTC Migraine Medication Market Size (2018-2029)
8.2 China OTC Migraine Medication Market Size by Type
8.2.1 China OTC Migraine Medication Market Size by Type (2018-2024)
8.2.2 China OTC Migraine Medication Market Size by Type (2024-2029)
8.2.3 China OTC Migraine Medication Market Share by Type (2018-2029)
8.3 China OTC Migraine Medication Market Size by Application
8.3.1 China OTC Migraine Medication Market Size by Application (2018-2024)
8.3.2 China OTC Migraine Medication Market Size by Application (2024-2029)
8.3.3 China OTC Migraine Medication Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia OTC Migraine Medication Market Size (2018-2029)
9.2 Asia OTC Migraine Medication Market Size by Type
9.2.1 Asia OTC Migraine Medication Market Size by Type (2018-2024)
9.2.2 Asia OTC Migraine Medication Market Size by Type (2024-2029)
9.2.3 Asia OTC Migraine Medication Market Share by Type (2018-2029)
9.3 Asia OTC Migraine Medication Market Size by Application
9.3.1 Asia OTC Migraine Medication Market Size by Application (2018-2024)
9.3.2 Asia OTC Migraine Medication Market Size by Application (2024-2029)
9.3.3 Asia OTC Migraine Medication Market Share by Application (2018-2029)
9.4 Asia OTC Migraine Medication Market Size by Region
9.4.1 Asia OTC Migraine Medication Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia OTC Migraine Medication Market Size by Region (2018-2024)
9.4.3 Asia OTC Migraine Medication Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America OTC Migraine Medication Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Type
10.2.1 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America OTC Migraine Medication Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Application
10.3.1 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America OTC Migraine Medication Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country
10.4.1 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson OTC Migraine Medication Introduction
11.1.4 Johnson & Johnson Revenue in OTC Migraine Medication Business (2018-2024)
11.1.5 Johnson & Johnson Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK OTC Migraine Medication Introduction
11.2.4 GSK Revenue in OTC Migraine Medication Business (2018-2024)
11.2.5 GSK Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer OTC Migraine Medication Introduction
11.3.4 Bayer Revenue in OTC Migraine Medication Business (2018-2024)
11.3.5 Bayer Recent Developments
11.4 Haleon
11.4.1 Haleon Company Details
11.4.2 Haleon Business Overview
11.4.3 Haleon OTC Migraine Medication Introduction
11.4.4 Haleon Revenue in OTC Migraine Medication Business (2018-2024)
11.4.5 Haleon Recent Developments
11.5 Tongde Pharmacy
11.5.1 Tongde Pharmacy Company Details
11.5.2 Tongde Pharmacy Business Overview
11.5.3 Tongde Pharmacy OTC Migraine Medication Introduction
11.5.4 Tongde Pharmacy Revenue in OTC Migraine Medication Business (2018-2024)
11.5.5 Tongde Pharmacy Recent Developments
11.6 Huazhong Pharmaceutical
11.6.1 Huazhong Pharmaceutical Company Details
11.6.2 Huazhong Pharmaceutical Business Overview
11.6.3 Huazhong Pharmaceutical OTC Migraine Medication Introduction
11.6.4 Huazhong Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024)
11.6.5 Huazhong Pharmaceutical Recent Developments
11.7 Weisen Pharmaceutical
11.7.1 Weisen Pharmaceutical Company Details
11.7.2 Weisen Pharmaceutical Business Overview
11.7.3 Weisen Pharmaceutical OTC Migraine Medication Introduction
11.7.4 Weisen Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024)
11.7.5 Weisen Pharmaceutical Recent Developments
11.8 DIAO GROUP
11.8.1 DIAO GROUP Company Details
11.8.2 DIAO GROUP Business Overview
11.8.3 DIAO GROUP OTC Migraine Medication Introduction
11.8.4 DIAO GROUP Revenue in OTC Migraine Medication Business (2018-2024)
11.8.5 DIAO GROUP Recent Developments
11.9 Jiheng Pharmaceutical
11.9.1 Jiheng Pharmaceutical Company Details
11.9.2 Jiheng Pharmaceutical Business Overview
11.9.3 Jiheng Pharmaceutical OTC Migraine Medication Introduction
11.9.4 Jiheng Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024)
11.9.5 Jiheng Pharmaceutical Recent Developments
11.10 Dirui Pharmaceutical
11.10.1 Dirui Pharmaceutical Company Details
11.10.2 Dirui Pharmaceutical Business Overview
11.10.3 Dirui Pharmaceutical OTC Migraine Medication Introduction
11.10.4 Dirui Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024)
11.10.5 Dirui Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Migraine Medication Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of NSAIDs
Table 3. Key Players of Acetaminophen
Table 4. Key Players of Others
Table 5. Global OTC Migraine Medication Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global OTC Migraine Medication Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global OTC Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global OTC Migraine Medication Market Share by Region (2018-2024)
Table 9. Global OTC Migraine Medication Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global OTC Migraine Medication Market Share by Region (2024-2029)
Table 11. OTC Migraine Medication Market Trends
Table 12. OTC Migraine Medication Market Drivers
Table 13. OTC Migraine Medication Market Challenges
Table 14. OTC Migraine Medication Market Restraints
Table 15. Global OTC Migraine Medication Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global OTC Migraine Medication Revenue Share by Players (2018-2024)
Table 17. Global Top OTC Migraine Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Migraine Medication as of 2022)
Table 18. Global OTC Migraine Medication Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by OTC Migraine Medication Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of OTC Migraine Medication, Headquarters and Area Served
Table 21. Global Key Players of OTC Migraine Medication, Product and Application
Table 22. Global Key Players of OTC Migraine Medication, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global OTC Migraine Medication Revenue Market Share by Type (2018-2024)
Table 26. Global OTC Migraine Medication Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global OTC Migraine Medication Revenue Market Share by Type (2024-2029)
Table 28. Global OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global OTC Migraine Medication Revenue Share by Application (2018-2024)
Table 30. Global OTC Migraine Medication Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global OTC Migraine Medication Revenue Share by Application (2024-2029)
Table 32. North America OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America OTC Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America OTC Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America OTC Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America OTC Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America OTC Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe OTC Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe OTC Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe OTC Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe OTC Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe OTC Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 46. China OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 47. China OTC Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 48. China OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 49. China OTC Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia OTC Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia OTC Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia OTC Migraine Medication Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia OTC Migraine Medication Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia OTC Migraine Medication Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America OTC Migraine Medication Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America OTC Migraine Medication Market Size by Country (2024-2029) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson OTC Migraine Medication Product
Table 67. Johnson & Johnson Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK OTC Migraine Medication Product
Table 72. GSK Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 73. GSK Recent Developments
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer OTC Migraine Medication Product
Table 77. Bayer Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 78. Bayer Recent Developments
Table 79. Haleon Company Details
Table 80. Haleon Business Overview
Table 81. Haleon OTC Migraine Medication Product
Table 82. Haleon Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 83. Haleon Recent Developments
Table 84. Tongde Pharmacy Company Details
Table 85. Tongde Pharmacy Business Overview
Table 86. Tongde Pharmacy OTC Migraine Medication Product
Table 87. Tongde Pharmacy Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 88. Tongde Pharmacy Recent Developments
Table 89. Huazhong Pharmaceutical Company Details
Table 90. Huazhong Pharmaceutical Business Overview
Table 91. Huazhong Pharmaceutical OTC Migraine Medication Product
Table 92. Huazhong Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 93. Huazhong Pharmaceutical Recent Developments
Table 94. Weisen Pharmaceutical Company Details
Table 95. Weisen Pharmaceutical Business Overview
Table 96. Weisen Pharmaceutical OTC Migraine Medication Product
Table 97. Weisen Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 98. Weisen Pharmaceutical Recent Developments
Table 99. DIAO GROUP Company Details
Table 100. DIAO GROUP Business Overview
Table 101. DIAO GROUP OTC Migraine Medication Product
Table 102. DIAO GROUP Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 103. DIAO GROUP Recent Developments
Table 104. Jiheng Pharmaceutical Company Details
Table 105. Jiheng Pharmaceutical Business Overview
Table 106. Jiheng Pharmaceutical OTC Migraine Medication Product
Table 107. Jiheng Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 108. Jiheng Pharmaceutical Recent Developments
Table 109. Dirui Pharmaceutical Company Details
Table 110. Dirui Pharmaceutical Business Overview
Table 111. Dirui Pharmaceutical OTC Migraine Medication Product
Table 112. Dirui Pharmaceutical Revenue in OTC Migraine Medication Business (2018-2024) & (US$ Million)
Table 113. Dirui Pharmaceutical Recent Developments
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Migraine Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global OTC Migraine Medication Market Share by Type: 2022 VS 2029
Figure 3. NSAIDs Features
Figure 4. Acetaminophen Features
Figure 5. Others Features
Figure 6. Global OTC Migraine Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global OTC Migraine Medication Market Share by Application: 2022 VS 2029
Figure 8. Drug Stores Case Studies
Figure 9. Hospitals Case Studies
Figure 10. OTC Migraine Medication Report Years Considered
Figure 11. Global OTC Migraine Medication Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global OTC Migraine Medication Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global OTC Migraine Medication Market Share by Region: 2022 VS 2029
Figure 14. Global OTC Migraine Medication Market Share by Players in 2022
Figure 15. Global Top OTC Migraine Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Migraine Medication as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by OTC Migraine Medication Revenue in 2022
Figure 17. North America OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America OTC Migraine Medication Market Share by Type (2018-2029)
Figure 19. North America OTC Migraine Medication Market Share by Application (2018-2029)
Figure 20. North America OTC Migraine Medication Market Share by Country (2018-2029)
Figure 21. United States OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe OTC Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe OTC Migraine Medication Market Share by Type (2018-2029)
Figure 25. Europe OTC Migraine Medication Market Share by Application (2018-2029)
Figure 26. Europe OTC Migraine Medication Market Share by Country (2018-2029)
Figure 27. Germany OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China OTC Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China OTC Migraine Medication Market Share by Type (2018-2029)
Figure 35. China OTC Migraine Medication Market Share by Application (2018-2029)
Figure 36. Asia OTC Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia OTC Migraine Medication Market Share by Type (2018-2029)
Figure 38. Asia OTC Migraine Medication Market Share by Application (2018-2029)
Figure 39. Asia OTC Migraine Medication Market Share by Region (2018-2029)
Figure 40. Japan OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America OTC Migraine Medication Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America OTC Migraine Medication Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America OTC Migraine Medication Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America OTC Migraine Medication Market Share by Country (2018-2029)
Figure 50. Brazil OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries OTC Migraine Medication Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Johnson & Johnson Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 57. GSK Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 58. Bayer Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 59. Haleon Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 60. Tongde Pharmacy Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 61. Huazhong Pharmaceutical Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 62. Weisen Pharmaceutical Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 63. DIAO GROUP Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 64. Jiheng Pharmaceutical Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 65. Dirui Pharmaceutical Revenue Growth Rate in OTC Migraine Medication Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed